FIND YOUR NEAREST STUDY CENTRE

Queenslanders living with generalised myasthenia gravis (gMG) may be eligible to participate in the MyClad Study, a clinical research study currently enrolling participants across Australia, including through study centres in Queensland.

Myasthenia Gravis Association of Queensland is pleased to support awareness of the Queensland research sites participating in the MyClad Study and to help Queenslanders living with MG learn more about opportunities to contribute to research.

The MyClad Study is researching an investigational medication taken by mouth for people living with gMG. The study aims to learn more about the safety of the investigational medication and its ability to improve gMG symptoms. 

Who may be eligible?

You may be eligible to participate in the MyClad Study if you:

• are aged 18 years or older
• have a confirmed diagnosis of myasthenia gravis with generalised muscle weakness.

Your doctor or the study team will review the full study requirements and discuss your eligibility with you.

All study-related procedures and the investigational medication are provided at no cost to participants. Participation in the study is expected to last approximately three years. 

Find your nearest MyClad Study Centre

The MyClad Study is open to eligible participants across Australia, including through study centres in Queensland.

To see which study centre is closest to you, visit the MyClad Study website and enter your postcode using the Find Your Nearest Study Centre search.

FIND YOUR NEAREST STUDY CENTRE

Find out more

If you are interested in participating in the MyClad Study, speak with your treating doctor about whether the study may be suitable for you.

You can also find further information in the MyClad participant resources below, including more information about the study, eligibility and what participation may involve.

Download the MyClad Patient Flyer

MGAQ is pleased to support awareness of clinical research opportunities available to Queenslanders living with myasthenia gravis and the work of Queensland research sites contributing to MG research.

Participation in any clinical trial is voluntary. This information is provided for general awareness and does not constitute medical advice or an endorsement of the investigational treatment. Please discuss your individual circumstances with your healthcare professional and the relevant study team.